Class II · ModerateRecall completed
Accupril (Quinapril HCl Tablets) 40 mg
Could cause temporary or reversible harm; serious harm is unlikely.
Does this affect you?
Check your lot numberLots: DX6031 Exp. MAR 31 2023; CK6260 Exp. MAY 31 2022
Where it was soldNationwide and Puerto Rico
Find the lot number printed on your box or bottle. If it matches — and you take this medicine — call your pharmacist. Don't stop a prescribed medicine on your own.
What happened
CGMP Deviations: Contains N-nitrosoquinapril above the acceptable limits.
What to do
- Check the lot number and expiry on your medicine against the recall above.
- Talk to your pharmacist or doctor before changing anything — don't stop on your own.
- Report any problems to FDA MedWatch (1-800-FDA-1088 or fda.gov/medwatch).
Who makes it
| Distributed by / for | Parke-Davis Division of Pfizer Inc. NY, NY 10017 |
| NDC | 0071-0535-23 |
Show the full FDA record
| Full product label | Accupril (Quinapril HCl Tablets) 40 mg, 90 Tablets, Rx only NDC 0071-0535-23 Distributed by: Parke-Davis Division of Pfizer Inc. NY, NY 10017 |
| Recalling firm | Pfizer Inc. |
| Distribution | Nationwide and Puerto Rico |
| Quantity | 8346 bottles |
| Recall initiated | 2022-04-22 |
| Report date | 2022-05-25 |
| Recall completed | 2023-10-05 |
| Recall number | D-0874-2022 |
| Classification | Class II |
| FDA status | Terminated |
| Origin on file | New York NY United States |
Source: U.S. FDA enforcement database (openFDA). Look this up on the official FDA recalls site ↗
This is public FDA recall information, not medical advice. A recall does not always mean your specific bottle is affected. Never stop a prescribed medicine without asking your pharmacist or doctor.